Q2 2018
Released Aug 7, 2018, before the open
10-Q filed Aug 7, 2018, 38 days after period end · 0001144204-18-042231
Q2 2018 · 10-Q
Revenue$0.00$0.00 — vs Q2 2017−100.0% vs Q1 2018
Net Income-$3.26M-$3.26M N/M vs Q2 2017N/M vs Q1 2018
EPS Diluted-$0.15-$0.15 N/M vs Q2 2017N/M vs Q1 2018
Operating Income-$3,164,409N/M
Operating Cash Flowderived-$2,740,125N/M
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q2 2018 | Q2 2017 | Q2 2016 | Q2 2015 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | — | — |
| Net Income | -$3.26M | -$6.09M | -$5.76M | -$4.25M |
| EPS Diluted | -$0.15 | -$0.31 | -$0.32 | -$0.26 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lipocine Inc. · CIK 1535955 · Engraved from SEC EDGAR